110 related articles for article (PubMed ID: 32877908)
21. Expression of Janus Kinase 1 in vitiligo & psoriasis before and after narrow band UVB: a case-control study.
Nada HR; El Sharkawy DA; Elmasry MF; Rashed LA; Mamdouh S
Arch Dermatol Res; 2018 Jan; 310(1):39-46. PubMed ID: 29127481
[TBL] [Abstract][Full Text] [Related]
22. Tricyclic covalent inhibitors selectively target Jak3 through an active site thiol.
Goedken ER; Argiriadi MA; Banach DL; Fiamengo BA; Foley SE; Frank KE; George JS; Harris CM; Hobson AD; Ihle DC; Marcotte D; Merta PJ; Michalak ME; Murdock SE; Tomlinson MJ; Voss JW
J Biol Chem; 2015 Feb; 290(8):4573-4589. PubMed ID: 25552479
[TBL] [Abstract][Full Text] [Related]
23. Activation of JAK3, but not JAK1, is critical for IL-2-induced proliferation and STAT5 recruitment by a COOH-terminal region of the IL-2 receptor beta-chain.
Kirken RA; Rui H; Malabarba MG; Howard OM; Kawamura M; O'Shea JJ; Farrar WL
Cytokine; 1995 Oct; 7(7):689-700. PubMed ID: 8580378
[TBL] [Abstract][Full Text] [Related]
24. Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil.
de Araújo Santos FJ; da Silva LS; Júnior JDES; Ramos de Mesquita TG; de Souza MLG; de Andrade Júnior MC; Talhari S; Ramasawmy R
PLoS One; 2019; 14(8):e0220572. PubMed ID: 31393896
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous JAK Expression in Vitiligo.
Abdel Motaleb AA; Tawfik YM; El-Mokhtar MA; Elkady S; El-Gazzar AF; ElSayed SK; Awad SM
J Cutan Med Surg; 2021; 25(2):157-162. PubMed ID: 33174479
[TBL] [Abstract][Full Text] [Related]
26. Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity.
Andrés RM; Hald A; Johansen C; Kragballe K; Iversen L
Exp Dermatol; 2013 May; 22(5):323-8. PubMed ID: 23614738
[TBL] [Abstract][Full Text] [Related]
27. Receptor expression is essential for proliferation induced by dimerized Jak kinases.
Fujii H
Biochem Biophys Res Commun; 2008 Jun; 370(4):557-60. PubMed ID: 18381062
[TBL] [Abstract][Full Text] [Related]
28. Cell type-specific roles of Jak3 in IL-2-induced proliferative signal transduction.
Fujii H
Biochem Biophys Res Commun; 2007 Mar; 354(3):825-9. PubMed ID: 17266928
[TBL] [Abstract][Full Text] [Related]
29. Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study.
Magalhães RF; Biral AC; Pancoto JA; Donadi EA; Mendes CT; Magna LA; Kraemer MH
Int J Dermatol; 2010 Oct; 49(10):1133-40. PubMed ID: 20931685
[TBL] [Abstract][Full Text] [Related]
30. JAK3 mutants transform hematopoietic cells through JAK1 activation, causing T-cell acute lymphoblastic leukemia in a mouse model.
Degryse S; de Bock CE; Cox L; Demeyer S; Gielen O; Mentens N; Jacobs K; Geerdens E; Gianfelici V; Hulselmans G; Fiers M; Aerts S; Meijerink JP; Tousseyn T; Cools J
Blood; 2014 Nov; 124(20):3092-100. PubMed ID: 25193870
[TBL] [Abstract][Full Text] [Related]
31. 3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models.
Soth M; Hermann JC; Yee C; Alam M; Barnett JW; Berry P; Browner MF; Frank K; Frauchiger S; Harris S; He Y; Hekmat-Nejad M; Hendricks T; Henningsen R; Hilgenkamp R; Ho H; Hoffman A; Hsu PY; Hu DQ; Itano A; Jaime-Figueroa S; Jahangir A; Jin S; Kuglstatter A; Kutach AK; Liao C; Lynch S; Menke J; Niu L; Patel V; Railkar A; Roy D; Shao A; Shaw D; Steiner S; Sun Y; Tan SL; Wang S; Vu MD
J Med Chem; 2013 Jan; 56(1):345-56. PubMed ID: 23214979
[TBL] [Abstract][Full Text] [Related]
32. Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia.
Bellanger D; Jacquemin V; Chopin M; Pierron G; Bernard OA; Ghysdael J; Stern MH
Leukemia; 2014 Feb; 28(2):417-9. PubMed ID: 24048415
[No Abstract] [Full Text] [Related]
33. Involvement of JAK1, JAK2, and JAK3 in Stimulation of Functional Activity of Mesenchymal Progenitor Cells by Fibroblast Growth Factor.
Zyuz'kov GN; Zhdanov VV; Udut EV; Miroshnichenko LA; Simanina EV; Polyakova TY; Stavrova LA; Udut VV; Minakova MY; Dygai AM
Bull Exp Biol Med; 2016 Dec; 162(2):240-243. PubMed ID: 27905037
[TBL] [Abstract][Full Text] [Related]
34. Lack of association between the G-2548A polymorphism of the leptin gene and psoriasis in a Turkish population.
Kara N; Aydin F; Senturk N; Gunes S; Canturk MT; Bagci H; Bek Y; Turanli AY
Int J Dermatol; 2007 Dec; 46(12):1271-4. PubMed ID: 18173522
[TBL] [Abstract][Full Text] [Related]
35. Association between single nucleotide polymorphisms IL17RA rs4819554 and IL17E rs79877597 and Psoriasis in a Spanish cohort.
Batalla A; Coto E; González-Lara L; González-Fernández D; Gómez J; Aranguren TF; Queiro R; Santos-Juanes J; López-Larrea C; Coto-Segura P
J Dermatol Sci; 2015 Nov; 80(2):111-5. PubMed ID: 26347322
[TBL] [Abstract][Full Text] [Related]
36. Association of paraoxonase 1 (PON1) L55M and PON1 Q192R gene polymorphisms and risk of psoriasis.
Kalkan G; Seçkin HY; Benli İ; Akbaş A; Ateş Ö; Özyurt H; Baş Y; Oğrum A; Pancar GŞ
G Ital Dermatol Venereol; 2019 Jun; 154(3):321-326. PubMed ID: 28399619
[TBL] [Abstract][Full Text] [Related]
37. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
Dymock BW; See CS
Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
[TBL] [Abstract][Full Text] [Related]
38. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha.
Malabarba MG; Kirken RA; Rui H; Koettnitz K; Kawamura M; O'Shea JJ; Kalthoff FS; Farrar WL
J Biol Chem; 1995 Apr; 270(16):9630-7. PubMed ID: 7721895
[TBL] [Abstract][Full Text] [Related]
39. Role of JAK1, JAK2, and JAK3 in Functional Stimulation of Mesenchymal Precursor Cells by Alkaloid Songorine.
Zyuz'kov GN; Udut EV; Miroshnichenko LA; Simanina EV; Polyakova TY; Stavrova LA; Udut VV; Minakova MY; Dygai AM; Chaikovskii AV; Agafonov VI; Zhdanov VV
Bull Exp Biol Med; 2017 Aug; 163(4):443-446. PubMed ID: 28853089
[TBL] [Abstract][Full Text] [Related]
40. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
